conclusions chronic hepatitis c-related liver diseases impose a substantial economic burden on patients, families and the society. the current study provides useful information on cost of treatment and work loss for different disease states, which can be further used in cost-effectiveness evaluations. results the total annual cost per patient for chronic hepatitis c, cirrhosis and hepatocellula...

Osteoporosis and osteomalacia are, to date, among the most common metabolic diseases in the world. Lately, an association between metabolic bone diseases and chronic liver disease has been increasingly reported, inducing many authors to create a new nosographic entity known as 'hepatic osteodystrophy.' The importance of such a condition is further increased by the morbidity of these two disease...